Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Patriot's CEO owes its shareholders at least a letter

regarding the Markman ruling. More importantly shareholders deserve to know what the BoD's business plan is for PTSC. Now that M&A&I are completely off the table, what is the immediate plan to bring value to shareholders.

Share
New Message
Please login to post a reply